Hyperbaric Oxygen Therapy in Systemic Inflammatory Response Syndrome
(1) Background: Systemic inflammatory response syndrome (SIRS) can occur due to a large number of traumatic or non-traumatic diseases. Hyperbaric oxygen therapy (HBOT) may be used as a main or adjuvant treatment for inflammation, leading to the main aim of this study, which was to verify the applica...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-01-01
|
| Series: | Veterinary Sciences |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2306-7381/9/2/33 |
| _version_ | 1827652335250178048 |
|---|---|
| author | Débora Gouveia Mariana Chichorro Ana Cardoso Carla Carvalho Cátia Silva Tiago Coelho Isabel Dias António Ferreira Ângela Martins |
| author_facet | Débora Gouveia Mariana Chichorro Ana Cardoso Carla Carvalho Cátia Silva Tiago Coelho Isabel Dias António Ferreira Ângela Martins |
| author_sort | Débora Gouveia |
| collection | DOAJ |
| description | (1) Background: Systemic inflammatory response syndrome (SIRS) can occur due to a large number of traumatic or non-traumatic diseases. Hyperbaric oxygen therapy (HBOT) may be used as a main or adjuvant treatment for inflammation, leading to the main aim of this study, which was to verify the applicability of HBOT as a safe and tolerable tool in SIRS-positive dogs. (2) Methods: This prospective cohort study included 49 dogs who showed two or more parameters of SIRS, divided into the Traumatic Study Group (n = 32) and the Non-Traumatic Study Group (n = 17). All dogs were submitted to HBOT for 60–90 min sessions, with 2.4–2.8 ATA. (3) Results: This study revealed that 73.5% (36/49) of dogs showed improvement, and the minimum number of HBOT sessions was two, with a mean of 12.73. The number of days between diagnosis and the beginning of HBOT showed statistical significance (<i>p</i> = 0.031) relative to the clinical outcome. No dogs showed any major side effects. (4) Conclusions: We concluded that HBOT may be safe and tolerable for SIRS-positive dogs, and that it should be applied as early as possible. |
| first_indexed | 2024-03-09T20:54:03Z |
| format | Article |
| id | doaj.art-f0d67a2211aa4e59b0a8325fcd77a3a0 |
| institution | Directory Open Access Journal |
| issn | 2306-7381 |
| language | English |
| last_indexed | 2024-03-09T20:54:03Z |
| publishDate | 2022-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Veterinary Sciences |
| spelling | doaj.art-f0d67a2211aa4e59b0a8325fcd77a3a02023-11-23T22:27:33ZengMDPI AGVeterinary Sciences2306-73812022-01-01923310.3390/vetsci9020033Hyperbaric Oxygen Therapy in Systemic Inflammatory Response SyndromeDébora Gouveia0Mariana Chichorro1Ana Cardoso2Carla Carvalho3Cátia Silva4Tiago Coelho5Isabel Dias6António Ferreira7Ângela Martins8Arrábida Veterinary Hospital—Lisbon Animal Regenerative and Rehabilitation Center, 2675-655 Odivelas, PortugalSchool of Agrarian and Veterinary Sciences, Department of Veterinary Science, University of Trás-os-Montes and Alto Douro, 5000-801 Vila Real, PortugalArrábida Veterinary Hospital—Lisbon Animal Regenerative and Rehabilitation Center, 2675-655 Odivelas, PortugalArrábida Veterinary Hospital—Lisbon Animal Regenerative and Rehabilitation Center, 2675-655 Odivelas, PortugalArrábida Veterinary Hospital—Lisbon Animal Regenerative and Rehabilitation Center, 2675-655 Odivelas, PortugalArrábida Veterinary Hospital—Lisbon Animal Regenerative and Rehabilitation Center, 2675-655 Odivelas, PortugalSchool of Agrarian and Veterinary Sciences, Department of Veterinary Science, University of Trás-os-Montes and Alto Douro, 5000-801 Vila Real, PortugalFaculty of Veterinary Medicine, University of Lisbon, 1300-477 Lisbon, PortugalArrábida Veterinary Hospital—Lisbon Animal Regenerative and Rehabilitation Center, 2675-655 Odivelas, Portugal(1) Background: Systemic inflammatory response syndrome (SIRS) can occur due to a large number of traumatic or non-traumatic diseases. Hyperbaric oxygen therapy (HBOT) may be used as a main or adjuvant treatment for inflammation, leading to the main aim of this study, which was to verify the applicability of HBOT as a safe and tolerable tool in SIRS-positive dogs. (2) Methods: This prospective cohort study included 49 dogs who showed two or more parameters of SIRS, divided into the Traumatic Study Group (n = 32) and the Non-Traumatic Study Group (n = 17). All dogs were submitted to HBOT for 60–90 min sessions, with 2.4–2.8 ATA. (3) Results: This study revealed that 73.5% (36/49) of dogs showed improvement, and the minimum number of HBOT sessions was two, with a mean of 12.73. The number of days between diagnosis and the beginning of HBOT showed statistical significance (<i>p</i> = 0.031) relative to the clinical outcome. No dogs showed any major side effects. (4) Conclusions: We concluded that HBOT may be safe and tolerable for SIRS-positive dogs, and that it should be applied as early as possible.https://www.mdpi.com/2306-7381/9/2/33SIRSHBOTtraumaticdogsATA |
| spellingShingle | Débora Gouveia Mariana Chichorro Ana Cardoso Carla Carvalho Cátia Silva Tiago Coelho Isabel Dias António Ferreira Ângela Martins Hyperbaric Oxygen Therapy in Systemic Inflammatory Response Syndrome Veterinary Sciences SIRS HBOT traumatic dogs ATA |
| title | Hyperbaric Oxygen Therapy in Systemic Inflammatory Response Syndrome |
| title_full | Hyperbaric Oxygen Therapy in Systemic Inflammatory Response Syndrome |
| title_fullStr | Hyperbaric Oxygen Therapy in Systemic Inflammatory Response Syndrome |
| title_full_unstemmed | Hyperbaric Oxygen Therapy in Systemic Inflammatory Response Syndrome |
| title_short | Hyperbaric Oxygen Therapy in Systemic Inflammatory Response Syndrome |
| title_sort | hyperbaric oxygen therapy in systemic inflammatory response syndrome |
| topic | SIRS HBOT traumatic dogs ATA |
| url | https://www.mdpi.com/2306-7381/9/2/33 |
| work_keys_str_mv | AT deboragouveia hyperbaricoxygentherapyinsystemicinflammatoryresponsesyndrome AT marianachichorro hyperbaricoxygentherapyinsystemicinflammatoryresponsesyndrome AT anacardoso hyperbaricoxygentherapyinsystemicinflammatoryresponsesyndrome AT carlacarvalho hyperbaricoxygentherapyinsystemicinflammatoryresponsesyndrome AT catiasilva hyperbaricoxygentherapyinsystemicinflammatoryresponsesyndrome AT tiagocoelho hyperbaricoxygentherapyinsystemicinflammatoryresponsesyndrome AT isabeldias hyperbaricoxygentherapyinsystemicinflammatoryresponsesyndrome AT antonioferreira hyperbaricoxygentherapyinsystemicinflammatoryresponsesyndrome AT angelamartins hyperbaricoxygentherapyinsystemicinflammatoryresponsesyndrome |